Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.78%129.19M | -19.24%120.42M | -13.75%164.59M | -4.37%639.6M | -17.61%149.85M | -10.76%149.83M | -11.37%149.1M | 26.54%190.81M | -8.49%668.8M | 19.33%181.89M |
| Cost of revenue | -6.85%121.54M | -6.32%118.04M | -8.74%145.33M | 1.51%545.87M | -11.19%130.36M | -4.30%130.47M | -7.56%126M | 34.16%159.25M | -6.15%537.77M | 31.86%146.78M |
| Gross profit | -60.47%7.65M | -89.72%2.37M | -39.00%19.26M | -28.47%93.73M | -44.47%19.5M | -38.65%19.36M | -27.65%23.09M | -1.63%31.57M | -17.01%131.02M | -14.61%35.11M |
| Operating expense | -45.11%10.92M | -24.45%10.22M | -17.13%13.98M | 21.49%62.3M | 2.31%13.33M | 27.87%19.89M | -22.73%13.52M | 15.00%16.87M | -5.39%51.28M | 193.90%13.03M |
| Selling and administrative expenses | ---- | ---- | ---- | 13.60%72.68M | ---- | ---- | ---- | ---- | -0.74%63.98M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 1.85%25.86M | ---- | ---- | ---- | ---- | -2.92%25.39M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 21.33%46.82M | ---- | ---- | ---- | ---- | 0.75%38.59M | ---- |
| Depreciation and amortization | -4.16%4.96M | -1.05%5.17M | -4.08%5.03M | 17.51%20.78M | 2.08%5.14M | 9.85%5.17M | 11.18%5.22M | 10.71%5.24M | --17.68M | --5.04M |
| -Depreciation | -4.16%4.96M | -1.05%5.17M | -4.08%5.03M | 17.51%20.78M | 2.08%5.14M | 9.85%5.17M | 11.18%5.22M | 10.71%5.24M | --17.68M | --5.04M |
| Other operating expenses | -58.83%6.16M | -37.70%5.39M | -22.96%9.13M | 0.28%42.99M | 0.69%8.37M | 35.75%14.96M | -33.61%8.64M | 16.68%11.86M | --42.88M | --8.31M |
| Total other operating income | -18.15%203K | -2.33%336K | -20.44%179K | -18.28%10.38M | -43.99%177K | 39.33%248K | 57.08%344K | 0.45%225K | 23.83%12.7M | -96.68%316K |
| Operating profit | -520.15%-3.26M | -181.94%-7.84M | -64.10%5.28M | -60.59%31.42M | -72.08%6.16M | -103.29%-526K | -33.62%9.57M | -15.64%14.69M | -23.09%79.74M | -39.81%22.08M |
| Net non-operating interest income (expenses) | 26.71%631K | 12.23%615K | -27.37%483K | -34.82%-1.85M | -42.42%672K | -52.07%498K | -45.53%548K | -25.86%665K | -39.13%-1.37M | 244.90%1.17M |
| Non-operating interest income | -7.28%1.35M | -5.92%1.45M | -8.67%1.41M | -10.69%6.12M | -22.46%1.58M | -15.63%1.46M | -3.15%1.54M | 3.07%1.55M | --6.85M | --2.04M |
| Non-operating interest expense | -24.92%720K | -15.96%832K | 5.45%928K | 34.82%1.85M | 4.38%906K | 39.39%959K | 70.10%990K | 46.18%880K | 39.13%1.37M | 230.99%868K |
| Net investment income | 103.49%300K | -1,190.00%-3.61M | -117.74%-423K | -1,425.74%-3.14M | 211.48%3.35M | -17,092.00%-8.6M | -107.12%-280K | 472.50%2.38M | 237K | -3.01M |
| Gain(Loss) on financial instruments designated as cash flow hedges | -141.82%-92K | 211.11%20K | 8,200.00%81K | -352.59%-293K | -243.60%-494K | -47.99%220K | 98.07%-18K | -100.35%-1K | 116K | 344K |
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 28.57%180K | -82.96%23K | 465.22%84K | -396.45%-5.59M | -202.22%-5.84M | -76.94%140K | -10.00%135K | -146.00%-23K | -1.13M | -1.93M |
| Less:Impairment of capital assets | -70.00%3K | -83.33%2K | --0 | 9,291.84%4.5M | 26,994.12%4.57M | 400.00%10K | -14.29%12K | --1K | ---49K | ---17K |
| Less:Other special charges | -22.00%-183K | 82.99%-25K | -481.82%-84K | 73.29%-234K | 50.50%-50K | 75.37%-150K | 10.37%-147K | 144.00%22K | ---876K | ---101K |
| Less:Write off | ---- | ---- | ---- | -35.64%1.32M | -35.64%1.32M | ---- | ---- | ---- | --2.05M | --2.05M |
| Other non-operating income (expenses) | 20.74%780K | 30.15%803K | 19.60%720K | -104.62%-3.92M | 17.96%683K | 40.13%646K | 79.88%617K | 81.33%602K | -97.07%-1.92M | 130.84%579K |
| Income before tax | 80.80%-1.46M | -194.52%-9.99M | -66.05%6.22M | -66.45%25.65M | -76.42%4.53M | -141.21%-7.62M | -44.10%10.57M | -0.11%18.32M | -24.84%76.45M | -18.94%19.23M |
| Income tax | 246.73%964K | -121.15%-716K | -71.55%1.19M | -50.47%8.05M | -72.24%1.06M | -121.05%-657K | -26.05%3.39M | -2.47%4.18M | -36.24%16.26M | -43.92%3.8M |
| Net income | 65.13%-2.43M | -229.10%-9.28M | -64.42%5.03M | -70.76%17.6M | -77.46%3.48M | -145.30%-6.96M | -49.86%7.19M | 0.60%14.14M | -21.02%60.19M | -8.95%15.43M |
| Net income continuous operations | 65.13%-2.43M | -229.10%-9.28M | -64.42%5.03M | -70.76%17.6M | -77.46%3.48M | -145.30%-6.96M | -49.86%7.19M | 0.60%14.14M | -21.02%60.19M | -8.95%15.43M |
| Noncontrolling interests | 117.59%92K | -118.18%-32K | -62.52%196K | -43.54%588.46K | -126.01%-45K | -183.41%-523K | -16.98%176K | 92.28%523K | -26.28%1.04M | 66.68%173K |
| Net income attributable to the company | 60.87%-2.52M | -231.88%-9.25M | -64.50%4.83M | -71.24%17.01M | -76.90%3.52M | -143.68%-6.44M | -50.36%7.01M | -1.20%13.62M | -20.92%59.15M | -9.41%15.25M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 60.87%-2.52M | -231.88%-9.25M | -64.50%4.83M | -71.24%17.01M | -76.90%3.52M | -143.68%-6.44M | -50.36%7.01M | -1.20%13.62M | -20.92%59.15M | -9.41%15.25M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 60.50%-0.0047 | -231.54%-0.0171 | -64.29%0.009 | -71.23%0.0315 | -76.95%0.0065 | -143.59%-0.0119 | -50.38%0.013 | -1.18%0.0252 | -20.94%0.1095 | -9.62%0.0282 |
| Diluted earnings per share | 60.50%-0.0047 | -231.54%-0.0171 | 0 | -71.23%0.0315 | -76.95%0.0065 | -143.59%-0.0119 | -50.38%0.013 | -1.18%0.0252 | -20.94%0.1095 | -9.57%0.0282 |
| Dividend per share | 0 | 0 | -65.00%0.007 | -23.08%0.04 | 0 | -46.15%0.007 | 0.00%0.013 | 81.82%0.02 | 3.59%0.052 | 11.11%0.015 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.